USZ0 Stock Overview
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BPH Global Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0005 |
| 52 Week High | AU$0.05 |
| 52 Week Low | AU$0.0005 |
| Beta | 0.89 |
| 11 Month Change | 0% |
| 3 Month Change | -80.00% |
| 1 Year Change | -50.00% |
| 33 Year Change | -98.67% |
| 5 Year Change | n/a |
| Change since IPO | -98.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| USZ0 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | 0.6% |
| 1Y | -50.0% | -18.0% | 3.3% |
Return vs Industry: USZ0 underperformed the German Biotechs industry which returned -18% over the past year.
Return vs Market: USZ0 underperformed the German Market which returned 3.3% over the past year.
Price Volatility
| USZ0 volatility | |
|---|---|
| USZ0 Average Weekly Movement | 23.5% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: USZ0's share price has been volatile over the past 3 months.
Volatility Over Time: USZ0's weekly volatility has decreased from 263% to 23% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | n/a | Matthew Leonard | www.scu.com.sg |
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023.
BPH Global Ltd Fundamentals Summary
| USZ0 fundamental statistics | |
|---|---|
| Market cap | €972.64k |
| Earnings (TTM) | -€1.59m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.6x
P/E RatioIs USZ0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USZ0 income statement (TTM) | |
|---|---|
| Revenue | AU$0 |
| Cost of Revenue | AU$23.94k |
| Gross Profit | -AU$23.94k |
| Other Expenses | AU$2.54m |
| Earnings | -AU$2.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0066 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -70.9% |
How did USZ0 perform over the long term?
See historical performance and comparison